These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9742041)

  • 21. [The influence of RS-Timolol in comparison with R-Timolol and S-Timolol on the intraocular pressure in water-loaded rabbits].
    Czechowicz-Janicka K; Kamińska E; Staszkiewicz J; Terelak-Borys B; Oledzka K; Danysz A
    Klin Oczna; 1998; 100(5):259-61. PubMed ID: 9884519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained release timolol maleate loaded ocusert based on biopolymer composite.
    Nair RV; S S; Suresh A; K R A; Nair SC
    Int J Biol Macromol; 2018 Apr; 110():308-317. PubMed ID: 29341922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ophthalmic administration of a 10-fold-lower dose of conventional nanoliposome formulations caused levels of intraocular pressure similar to those induced by marketed eye drops.
    Arroyo CM; Quinteros D; Cózar-Bernal MJ; Palma SD; Rabasco AM; González-Rodríguez ML
    Eur J Pharm Sci; 2018 Jan; 111():186-194. PubMed ID: 28923571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
    Gupta H; Velpandian T; Jain S
    J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
    El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM
    J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
    Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
    Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous monitoring of circadian variations in intraocular pressure by telemetry system throughout a 12-week treatment with timolol maleate in rabbits.
    Akaishi T; Ishida N; Shimazaki A; Hara H; Kuwayama Y
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):436-44. PubMed ID: 16386085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model.
    Moosa RM; Choonara YE; du Toit LC; Tomar LK; Tyagi C; Kumar P; Carmichael TR; Pillay V
    Int J Pharm; 2014 May; 466(1-2):296-306. PubMed ID: 24607446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo.
    Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W
    Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.
    Wei G; Ding PT; Zheng JM; Lu WY
    Biomed Chromatogr; 2006 Jan; 20(1):67-71. PubMed ID: 15954162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
    Saroha A; Pandey P; Kaushik D
    Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
    Tan AY; LeVatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
    J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optic nerve vasomotor effects of topical beta-adrenergic antagonists in rabbits.
    Orgül S; Mansberger S; Bacon DR; Van Buskirk EM; Cioffi GA
    Am J Ophthalmol; 1995 Oct; 120(4):441-7. PubMed ID: 7573301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
    Rom M; Schwartz B; Bealka N
    J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timolol hemihydrate: a new formulation of timolol for the treatment of glaucoma.
    Stewart WC
    J Ocul Pharmacol Ther; 1996; 12(2):225-37. PubMed ID: 8773937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate.
    Joshi GV; Kevadiya BD; Patel HA; Bajaj HC; Jasra RV
    Int J Pharm; 2009 Jun; 374(1-2):53-7. PubMed ID: 19446759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of ocular drugs. 1. Timolol maleate.
    Kaufman HE
    Ophthalmology; 1980 Feb; 87(2):164-8. PubMed ID: 6104319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.